In the rapidly evolving landscape of life sciences, the challenges plaguing drug development have become more pronounced, prompting an urgent need for transformation. The industry has long grappled with prolonged cycle times, substantial costs, and steep complexities in clinical trials that delay
In the rapidly evolving digital landscape, Britain's National Health Service (NHS) has become an attractive target for cybercriminals. Over recent years, incidents have highlighted vulnerabilities in the system, posing significant risks to patient safety and service delivery. Two major cyberattacks
Recent advancements in biotechnology have paved the way for innovative solutions in DNA research, with automation playing a pivotal role. Thermo Fisher's KingFisher PlasmidPro system emerges as a significant breakthrough, promising to streamline the traditionally tedious plasmid DNA maxi-prep
Biovica International, known for its innovations in blood-based cancer monitoring, recently unveiled a strategic collaboration with a prominent US-based Tier-1 pharmaceutical company. This partnership reflects a mutual commitment to pioneering advancements in cancer treatment. The alliance
Recent developments have propelled the field of oncology drug development into a new era, primarily due to the integration of artificial intelligence. Startups like Pathos AI Inc. exemplify this shift by leveraging AI to streamline vital processes within oncology research. The company has
In the evolving landscape of clinical research, artificial intelligence (AI) has become an indispensable tool, yet the level of adoption and integration at clinical research sites remains inconsistent. AI's potential to enhance various aspects of clinical trials, from design to data management, has
